PENELYNNE FLORES: Open Payments
NPI 1477502110 · ASHBURN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 25 payments from 8 companies in 2025. Trend: 2023 $585 · 2024 $689 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $144 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $141 |
| AstraZeneca Pharmaceuticals LP | 5 | $115 |
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| Lilly USA, LLC | 2 | $39 |
| Genentech USA, Inc. | 1 | $27 |
| Greer Laboratories, Inc. | 1 | $24 |
| Organon LLC | 2 | $21 |
Products named: DUPIXENT, NEFFY, TEZSPIRE, AIRSUPRA, Rhapsido, Xolair, ORALAIR, VTAMA.
Industry payments across VA — which companies pay providers there.
